Vivimed Labs is currently trading at Rs. 106.30, up by 2.35 points or 2.26% from its previous closing of Rs. 103.95 on the BSE.
The scrip opened at Rs. 104.90 and has touched a high and low of Rs. 109.30 and Rs. 104.80 respectively. So far 210353 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 153.30 on 21-Sep-2017 and a 52 week low of Rs. 88.75 on 30-Dec-2016.
Last one week high and low of the scrip stood at Rs. 109.30 and Rs. 103.25 respectively. The current market cap of the company is Rs. 878.88 crore.
The promoters holding in the company stood at 36.05%, while Institutions and Non-Institutions held 7.35% and 56.60% respectively.
Vivimed Labs has signed definitive agreements and received funds to facilitate additional investment of $7.5 million (follow on of $42.5 million invested in September 2017) by OrbiMed Asia into the company’s subsidiary, Vivimed Labs (Mascarene), the holding entity of the company’s API business.
The proceeds of this additional investment will be utilized to drive business growth and, increase the company’s profitability by organic and inorganic growth opportunities.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
